Yu CT, Wu JK, Chang CC, Chen CL, Wei JC
Quick Takeaways Tesamorelin has robust clinical evidence for reducing visceral fat (15-17.5%), increasing lean mass (1.42 kg), and improving metabolic markers in human trials Ipamorelin selectively releases growth hormone without affecting cortisol or prolactin, making it the cleanest GHRP available Combining a GHRH with a GHRP creates synergistic GH pulsatility that mimics and amplifies your bodys natural growth hormone patterns My recommended protocol: Tesamorelin 1mg + Ipamorelin 100mcg, injected AM/PM, 5 days on/2 days off, 8 weeks on/8 weeks off What This Peptide Combination Actually Is Tesamorelin and Ipamorelin target different receptors in the growth hormone regulation system, which is precisely why they work so well together
A meta-analysis of 87,162 patients in 9 clinical trials showed that alogliptin was shown to be a safe drug for diabetic patients with cardiovascular complications [19,20,21]
This trend is instrumental in optimising the registration process for a new medicine in each individual country in terms of time, efficiency and quality, with minimal duplication of resources, time or cost
MOTS-C supports mitochondrial energy, insulin sensitivity and endurance
